AMBROZINE TRENT-JOHNNEY: Open Payments
NPI 1932243136 · LITHONIA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 27 payments from 12 companies in 2025. Trend: 2023 $651 · 2024 $453 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $115 |
| Amgen Inc. | 3 | $51 |
| Lilly USA, LLC | 2 | $49 |
| Novo Nordisk Inc | 3 | $42 |
| Dexcom, Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Boston Scientific Corporation | 1 | $23 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Kerendia, FARXIGA, MOUNJARO, AIRSUPRA, Dexcom G6 Transmitter, OTEZLA, Wegovy, LINZESS.
Industry payments across GA — which companies pay providers there.
